Catecholamine Synthesis Inhibitors [MoA] - N0000175361

Name: Table of NDC products with catecholamine synthesis inhibitors
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000175361
Pharmacologic Name	Catecholamine Synthesis Inhibitors
Pharmacologic Uses	catecholamine synthesis inhibitor
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Catecholamine Synthesis Inhibitors

The table contains 3 products whose active ingredient are classified under the same pharmacologic class Catecholamine Synthesis Inhibitors [MoA].

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
25010-305	Demser	Non-Proprietary Name: Metyrosine	Capsule	Oral	Bausch Health Us, Llc	ACTIVE
68682-310	Metyrosine	Non-Proprietary Name: Metyrosine	Capsule	Oral	Oceanside Pharmaceuticals	ACTIVE
69238-1621	Metyrosine	Non-Proprietary Name: Metyrosine	Capsule	Oral	Amneal Pharmaceuticals Ny Llc	ACTIVE